Yunxia Wang Selected Research

Yunxia Wang Research Topics

Disease

29	Neoplasms (Cancer) 05/2024 - 08/2011
7	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2020
6	Chronic Obstructive Pulmonary Disease (COPD) 03/2024 - 01/2018
6	Inflammation (Inflammations) 01/2020 - 04/2009
5	Lung Neoplasms (Lung Cancer) 11/2023 - 09/2017
5	Infections 09/2020 - 04/2009
4	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 10/2014
4	Pain (Aches) 05/2024 - 01/2008
4	Fibrosis (Cirrhosis) 03/2024 - 10/2014
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 09/2017
4	Disease Progression 12/2022 - 01/2015
4	Abdominal Aortic Aneurysm 12/2022 - 01/2017
4	Bacterial Infections (Bacterial Infection) 09/2020 - 10/2018
4	Wounds and Injuries (Trauma) 03/2020 - 07/2011
4	Myocardial Ischemia (Ischemic Heart Diseases) 11/2019 - 01/2008
4	Myotonia 07/2013 - 07/2011
3	Stroke (Strokes) 03/2024 - 12/2019
3	Atherosclerosis 10/2023 - 12/2019
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 02/2014
2	Aphasia (Dysphasia) 03/2024 - 11/2023
2	Lung Diseases (Lung Disease) 03/2024 - 01/2015
2	Pathologic Processes 11/2023 - 01/2023
2	Hyperplasia 01/2023 - 06/2021
2	Breast Neoplasms (Breast Cancer) 10/2022 - 06/2020
2	Diabetes Mellitus 01/2021 - 01/2020
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 09/2011
2	Body Weight (Weight, Body) 01/2020 - 01/2019
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019 - 01/2015
2	Cholangiocarcinoma 01/2019 - 01/2016
2	Hypoxia (Hypoxemia) 01/2019 - 10/2014
2	Non-alcoholic Fatty Liver Disease 11/2017 - 08/2017
2	Headache (Headaches) 03/2017 - 02/2017
2	Tuberculosis (Tuberculoses) 03/2016 - 08/2015
2	Rare Diseases (Rare Disease) 07/2013 - 10/2012
2	Neuralgia (Stump Neuralgia) 09/2011 - 09/2008
2	Leukemia 12/2002 - 11/2002
1	Rheumatoid Arthritis 05/2024

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2008
13	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2014
7	MicroRNAs (MicroRNA)IBA 06/2021 - 01/2013
6	EnzymesIBA 09/2022 - 05/2008
6	PolymersIBA 09/2022 - 10/2018
5	Messenger RNA (mRNA)IBA 01/2019 - 01/2008
4	Therapeutic UsesIBA 03/2024 - 06/2018
4	Particulate MatterIBA 11/2019 - 01/2018
4	Sodium Channels (Sodium Channel)IBA 07/2013 - 07/2011
3	Hematoxylin (Haematoxylon)IBA 03/2024 - 07/2011
3	Eosine Yellowish-(YS) (Eosin)IBA 03/2024 - 07/2011
3	Circular RNAIBA 09/2021 - 11/2019
3	Purinergic P2X3 ReceptorsIBA 11/2019 - 05/2008
3	CollagenIBA 08/2018 - 01/2015
3	ARQ 197IBA 01/2018 - 11/2016
3	CytokinesIBA 03/2016 - 01/2015
2	C-Reactive ProteinIBA 03/2024 - 01/2023
2	Matrix Metalloproteinases (MMPs)IBA 03/2024 - 01/2019
2	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2023
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2023 - 08/2019
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
2	LipopolysaccharidesIBA 01/2023 - 02/2010
2	naringeninIBA 12/2022 - 08/2017
2	Imiquimod (Aldara)FDA LinkGeneric 10/2022 - 10/2022
2	HydrogelsIBA 10/2022 - 09/2020
2	CarbonIBA 01/2022 - 06/2018
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2022 - 08/2018
2	Small Interfering RNA (siRNA)IBA 02/2020 - 01/2015
2	VimentinIBA 02/2020 - 01/2020
2	Long Noncoding RNAIBA 02/2020 - 01/2020
2	Pancreatic Elastase (Elastase)IBA 01/2020 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 08/2019
2	ElastinIBA 01/2020 - 01/2019
2	PolyphenolsIBA 01/2020 - 01/2017
2	InflammasomesIBA 11/2019 - 08/2018
2	SmokeIBA 05/2019 - 01/2018
2	Monoamine Oxidase (MAO)IBA 01/2019 - 01/2015
2	cycloastragenolIBA 01/2019 - 08/2018
2	derazantinibIBA 01/2019 - 01/2016
2	Sirtuin 1IBA 01/2019 - 11/2017
2	rasagiline (Azilect)FDA Link 01/2019 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 04/2009
2	Choline (Choline Chloride)IBA 08/2017 - 11/2015
2	Adenosine Triphosphate (ATP)IBA 01/2016 - 01/2008
2	ChloridesIBA 07/2013 - 07/2011
2	SodiumIBA 07/2013 - 08/2011
2	NAD (NADH)IBA 09/2011 - 12/2002
2	Tryptophan (L-Tryptophan)FDA Link 02/2010 - 04/2009
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 02/2010 - 04/2009
2	A-317491IBA 05/2008 - 01/2008
1	AlkaloidsIBA 05/2024
1	isoquinolineIBA 05/2024
1	BerberineIBA 05/2024
1	brucineIBA 05/2024

Therapy/Procedure

15	Therapeutics 05/2024 - 08/2011
4	Immunotherapy 10/2022 - 01/2019
3	Drug Therapy (Chemotherapy) 01/2020 - 08/2015
2	Injections 05/2024 - 10/2022
2	Transcranial Magnetic Stimulation 03/2024 - 11/2023
2	Photochemotherapy (Photodynamic Therapy) 11/2023 - 08/2019
2	Precision Medicine 10/2022 - 10/2022
2	Endovascular Procedures 03/2017 - 02/2017